Search Results - "Westerweel, P.E."

Reconstituted HDL Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes by van Oostrom, O, Nieuwdorp, M, Westerweel, P E, Hoefer, I E, Basser, R, Stroes, E S.G, Verhaar, M C

Get full text

Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism by de Jong, C. M. M., Blondon, M., Ay, C., Buchmuller, A., Beyer-Westendorf, J., Biechele, J., Bertoletti, L., Colombo, G., Donadini, M. P., Hendriks, S. V., Jara-Palomares, L., Nopp, S., Ruiz-Artacho, P., Stephan, P., Tromeur, C., Vanassche, T., Westerweel, P. E., Klok, F. A.

“…•Abnormal uterine bleeding (AUB) is highly incident among women of reproductive age treated with anticoagulants for venous thromboembolism.•Women with AUB,…”
Get full text

P014 - PROGNOSTIC IMPACT OF LOW MUSCLE MASS AND MUSCLE DENSITY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA by Rier, H.N., Kharagjitsing, H., Van Rosmalen, J., Van Vugt, J., Westerweel, P.E., De Jongh, E., Dinmohamed, A., Doorduijn, J., Kock, M., Levin, M.

Get full text

PROGNOSTIC IMPACT OF LOW MUSCLE MASS AND MUSCLE DENSITY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA by Rier, H.N., Kharagjitsing, H., Van Rosmalen, J., Van Vugt, J., Westerweel, P.E., De Jongh, E., Dinmohamed, A., Doorduijn, J., Kock, M., Levin, M.

Get full text

The upper extremity postthrombotic syndrome score: an international Delphi consensus study to determine the score’s functional disability component by Schropp, Ludo, Cats, Roos B., de Kleijn, Robert J.C.M.F., van Hattum, Eline S., Middeldorp, Saskia, Nijkeuter, Mathilde, Westerink, Jan, Petri, Bart-Jeroen, de Borst, Gert J., Schropp, L., Cats, R.B., de Kleijn, R.J.C.M.F., Black, S., Garcia, D., Meijer, K., Nijziel, M.R., Klappe, E.M., Geroulakos, G., van Ommen, C.H., van Rijn, M.J.E., Freischlag, J., Kruip, M.J.H.A., Huisman, M.V., Coppens, M., Teijink, J.A.W., Kakkos, S.K., Le Gal, G., Westerweel, P.E., Avila, M.L., Kreuziger, L. Baumann, Cate-Hoek, A.J. Ten, Lee, A.Y.Y., Koelemay, M.J., Srivastava, A., Hovens, M.M.C., Ünlü, Ç., Klok, F.A., Douketis, J., Stansby, G., Illig, K.A., Thompson, R.W., Bax, W.A., Poli, D., Kahn, S.R., van Hattum, E.S., Middeldorp, S., Nijkeuter, M., Westerink, J., Petri, B.J., de Borst, G.J.

“…In upper extremity thrombosis research, the occurrence of upper extremity postthrombotic syndrome (UE-PTS) is commonly used as the main outcome parameter…”
Get full text

Diffuse alveolar hemorrhage as an early complication of alemtuzumab treatment: A case report of a multiple sclerosis patient and an overview of 14 cases by Drop, B.R.H., Zemel, D., Wokke, B.H.A., van Oosten, B.W., Dik, S., Martins Jarnalo, C.O., Westerweel, P.E., de Beukelaar, J.W.K.

“…•Alemtuzumab-induced diffuse alveolar hemorrhage is an early complication.•In alemtuzumab-induced diffuse alveolar hemorrhage hemoptysis can initially be…”
Get full text

Misoprostol versus curettage in women with early pregnancy failure: impact on women's health-related quality of life. A randomized controlled trial by Graziosi, G.C.M., Bruinse, H.W., Reuwer, P.J.H., van Kessel, P.H., Westerweel, P.E., Mol, B.W.

“…BACKGROUND: We aimed to compare patients' health-related quality of life after a misoprostol strategy to a curettage in women with early pregnancy failure…”
Get full text

Th-P16:342 Endothelial progenitor cells are reduced in the metabolic syndrome and normalize after lipid-lowering therapy by Westerweel, P.E., Olijhock, J.K., Hoefer, I.E., Hajer, G.R., Van Oostrom, O., Visseren, F.L., Verhaar, M.C.

Get full text